Literature DB >> 4793880

Effect of rifampin on cutaneous hypersensitivity to purified protein derivative in humans.

P Mukerjee, S Schuldt, J E Kasik.   

Abstract

The effect of rifampin on cutaneous hypersensitivity was studied in 11 tuberculous patients. A suppressive effect was noted in eight patients, five of whom developed a negative response to the strength of purified protein derivative to which they had been shown to be previously sensitive. In one instance complete anergy to purified protein derivative was noted. It appears that rifampin has immunosuppressive effects in some patients when used in conventional doses.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4793880      PMCID: PMC444605          DOI: 10.1128/AAC.4.6.607

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  DECLINING TUBERCULIN SENSITIVITY WITH ADVANCING AGE.

Authors:  R N JOHNSTON; R T RITCHIE; I H MURRAY
Journal:  Br Med J       Date:  1963-09-21

2.  Cutaneous anergy and Hodgkin's disease.

Authors:  W W SCHIER
Journal:  N Engl J Med       Date:  1954-03-04       Impact factor: 91.245

3.  The ability of ACTH and cortisone to alter delayed type bacterial hypersensitivity.

Authors:  J B LONG; C B FAVOUR
Journal:  Bull Johns Hopkins Hosp       Date:  1950-09

4.  Rifampicin: an immunosuppressant?

Authors:  B M Dajani; M S Canady; J S Thompson; J E Kasik
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Effect of rifampicin on delayed-hypersensitivity reactions.

Authors:  G G Grassi; E Pozzi
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

6.  In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin.

Authors:  E Păunescu
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

7.  Tuberculin tests during the course of sarcoidosis in 350 patients.

Authors:  E L Chusid; R Shah; L E Siltzbach
Journal:  Am Rev Respir Dis       Date:  1971-07

8.  Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.

Authors:  R Newman; B Doster; F J Murray; S Ferebee
Journal:  Am Rev Respir Dis       Date:  1971-04

9.  Active pulmonary tuberculosis with negative tuberculin skin reactions.

Authors:  D C Kent; R Schwartz
Journal:  Am Rev Respir Dis       Date:  1967-03

10.  Effect of rifampin on the immune response in guinea pigs.

Authors:  B M Dajani; J E Kasik; J S Thompson
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

View more
  4 in total

1.  Immunosuppressant activity of the ansamycins.

Authors:  J E Kasik; M Monick; J S Thompson
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

2.  Comparison of antibacterial and antiimmune effects of certain rifamycins.

Authors:  J E Kasik; M Monick
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

3.  Immunological responsiveness of tuberculosis patients receiving rifampin.

Authors:  F L Ruben; A Winkelstein; I G Fotiadis
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

4.  Effects of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo.

Authors:  F R Venezio; C A DiVincenzo
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.